Literature DB >> 23686974

Baseline cognitive function, recurrent stroke, and risk of dementia in patients with stroke.

Pamela M Rist1, John Chalmers, Hisatomi Arima, Craig Anderson, Stephen Macmahon, Mark Woodward, Tobias Kurth, Christophe Tzourio.   

Abstract

BACKGROUND AND
PURPOSE: To determine the interrelationships between baseline Mini-Mental State Examination (MMSE) score and risk of overall dementia, post-recurrent stroke dementia, and dementia without recurrent stroke among patients with a history of stroke.
METHODS: Prospective cohort study among participants enrolled in the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) for whom baseline MMSE score was available. Baseline MMSE score was divided into 4 categories: 30, 29-27, 26-24, and <24. Participants were followed for incident dementia and recurrent stroke. Logistic regression models were used to examine the association between MMSE score and dementia.
RESULTS: Of the 6080 participants included in this analysis, 2493 had an MMSE score of 30, 1768 had a score of 29-28, 1369 had a score of 26-24, and 450 had a score of <24. Average follow-up time was 3.8 years. There were 407 cases of dementia, 106 of which were preceded by a recurrent stroke. The risk of overall dementia increased with decreasing MMSE score. However, the impact of MMSE score on the risk of dementia without recurrent stroke was much stronger than the impact of MMSE score on the risk of post-recurrent stroke dementia. For those with MMSE score <24, the risk of dementia without recurrent stroke was 47.89 (95% confidence interval, 28.57-80.26), whereas the risk of post-recurrent stroke dementia was only 7.17 (95% confidence interval, 3.70-13.89). Higher MMSE scores were even less strongly associated with the risk of post-recurrent stroke dementia.
CONCLUSIONS: Patients with stroke with low MMSE scores are at high risk of dementia over time, even in the absence of a recurrent stroke, and should therefore be followed closely for further cognitive decline.

Entities:  

Keywords:  cerebrovascular disease; cognitive functioning; dementia; epidemiology

Mesh:

Year:  2013        PMID: 23686974      PMCID: PMC3695012          DOI: 10.1161/STROKEAHA.111.680728

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee.

Authors:  C Tzourio; C Anderson
Journal:  J Hypertens Suppl       Date:  2000-05

3.  Intellectual decline after stroke: the Framingham Study.

Authors:  C S Kase; P A Wolf; M Kelly-Hayes; W B Kannel; A Beiser; R B D'Agostino
Journal:  Stroke       Date:  1998-04       Impact factor: 7.914

4.  Poststroke dementia: incidence and relationship to prestroke cognitive decline.

Authors:  H Hénon; I Durieu; D Guerouaou; F Lebert; F Pasquier; D Leys
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

5.  Long-term rate of change in memory functioning before and after stroke onset.

Authors:  Qianyi Wang; Benjamin D Capistrant; Amy Ehntholt; M Maria Glymour
Journal:  Stroke       Date:  2012-08-30       Impact factor: 7.914

6.  Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.

Authors:  N Chapman; R Huxley; C Anderson; M G Bousser; J Chalmers; S Colman; S Davis; G Donnan; S MacMahon; B Neal; C Warlow; M Woodward
Journal:  Stroke       Date:  2003-12-11       Impact factor: 7.914

7.  Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

Authors:  Christophe Tzourio; Craig Anderson; Neil Chapman; Mark Woodward; Bruce Neal; Stephen MacMahon; John Chalmers
Journal:  Arch Intern Med       Date:  2003-05-12

8.  Progressive dementia after first-ever stroke: a community-based follow-up study.

Authors:  V K Srikanth; J F I Anderson; G A Donnan; M M Saling; E Didus; R Alpitsis; H M Dewey; R A L Macdonell; A G Thrift
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

9.  Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders.

Authors: 
Journal:  Stroke       Date:  1989-10       Impact factor: 7.914

Review 10.  Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS.

Authors: 
Journal:  J Hypertens Suppl       Date:  1996-09
View more
  19 in total

Review 1.  Vascular cognitive impairment, a cardiovascular complication.

Authors:  Adiukwu Frances; Ofori Sandra; Ugbomah Lucy
Journal:  World J Psychiatry       Date:  2016-06-22

2.  Poststroke cognitive impairment and hippocampal neurovascular remodeling: the impact of diabetes and sex.

Authors:  Rebecca Ward; John Paul Valenzuela; Weiguo Li; Guangkuo Dong; Susan C Fagan; Adviye Ergul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-17       Impact factor: 4.733

Review 3.  Post-stroke cognitive impairment: epidemiology, mechanisms and management.

Authors:  Jia-Hao Sun; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2014-08

4.  Association of cognitive functioning, incident stroke, and mortality in older adults.

Authors:  Kumar B Rajan; Neelum T Aggarwal; Robert S Wilson; Susan A Everson-Rose; Denis A Evans
Journal:  Stroke       Date:  2014-08-07       Impact factor: 7.914

Review 5.  High blood pressure in dementia: How low can we go?

Authors:  Yuda Turana; Jeslyn Tengkawan; Yook-Chin Chia; Boon Wee Teo; Jinho Shin; Guru Prasad Sogunuru; Arieska Ann Soenarta; Huynh Van Minh; Peera Buranakitjaroen; Chen-Huan Chen; Jennifer Nailes; Satoshi Hoshide; Sungha Park; Saulat Siddique; Jorge Sison; Apichard Sukonthasarn; Jam Chin Tay; Tzung-Dau Wang; Narsingh Verma; Yu-Qing Zhang; Ji-Guang Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-09       Impact factor: 3.738

6.  Pulse Pressure and Cognitive Decline in Stroke Patients With White Matter Changes.

Authors:  Zhaolu Wang; Adrian Wong; Wenyan Liu; Jie Yang; Winnie C W Chu; Lisa Au; Alexander Lau; Yunyun Xiong; Vincent C T Mok
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-06-01       Impact factor: 3.738

Review 7.  Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study.

Authors:  Natalia S Rost; James F Meschia; Rebecca Gottesman; Lisa Wruck; Karl Helmer; Steven M Greenberg
Journal:  Stroke       Date:  2021-05-27       Impact factor: 10.170

8.  Mild cognitive impairment: vascular risk factors in community elderly in four cities of Hebei Province, China.

Authors:  Yumei Wang; Mei Song; Lulu Yu; Lan Wang; Cuixia An; Shunjiang Xun; Xiaochuan Zhao; Yuanyuan Gao; Xueyi Wang
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

9.  Systemic and Disease-Specific Risk Factors in Vascular Dementia: Diagnosis and Prevention.

Authors:  Efraim Jaul; Oded Meiron
Journal:  Front Aging Neurosci       Date:  2017-10-17       Impact factor: 5.750

10.  Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.

Authors:  Shanshan Li; Xinjiang Zhang; Qi Fang; Junshan Zhou; Meijuan Zhang; Hui Wang; Yan Chen; Biyun Xu; Yanfeng Wu; Lai Qian; Yun Xu
Journal:  Stroke Vasc Neurol       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.